v3.26.3
Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2026
Sep. 30, 2025
Sep. 30, 2026
Sep. 30, 2025
Income Statement [Abstract]        
Collaboration revenue $ 0 $ 0 $ 20,000 $ 0
Operating expenses        
Research and development 34,316 22,279 118,446 64,531
Selling, general and administrative 9,770 7,707 30,661 22,059
Total operating expenses 44,086 29,986 149,107 86,590
Loss from operations (44,086) (29,986) (129,107) (86,590)
Other income (expense):        
Interest income 3,851 3,061 12,400 8,870
Total other income, net 3,851 3,061 12,400 8,870
Net loss $ (40,235) $ (26,925) $ (116,707) $ (77,720)
Net loss per share attributable to common stockholders, basic $ (0.84) $ (0.71) $ (2.46) $ (2.15)
Net loss per share attributable to common stockholders, diluted $ (0.84) $ (0.71) $ (2.46) $ (2.15)
Weighted-average common shares outstanding, basic 47,768,633 37,931,170 47,494,757 36,223,887
Weighted-average common shares outstanding, diluted 47,768,633 37,931,170 47,494,757 36,223,887
Comprehensive loss:        
Net loss $ (40,235) $ (26,925) $ (116,707) $ (77,720)
Change in unrealized (losses) gains on investments, net of tax (845) 221 (2,661) 667
Total other comprehensive income (loss) (845) 221 (2,661) 667
Comprehensive loss $ (41,080) $ (26,704) $ (119,368) $ (77,053)